Ovarian remnant syndrome in an aromatase inhibitor-treated patient with BRCA2 mutation following bilateral oophorectomy.

Wei, Mei; Maurer, Kathryn A; Henry, N Lynn

Wei, Mei; Maurer, Kathryn A; Henry, N Lynn.

Affiliation

Wei M; Division of Oncology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah.
Maurer KA; Huntsman Cancer Institute, Salt Lake City, Utah.
Henry NL; Huntsman Cancer Institute, Salt Lake City, Utah.

Breast J ; 25(6): 1254-1256, 2019 11.

Article in En | MEDLINE | ID: mdl-31273878

Subject(s)

Aromatase Inhibitors/administration & dosage; Breast Neoplasms; Estradiol/blood; Ovarian Cysts/diagnostic imaging; Ovary; Postoperative Complications; Premenopause; Salpingo-oophorectomy/adverse effects; Adult; BRCA2 Protein/genetics; Breast Neoplasms/pathology; Breast Neoplasms/therapy; Diagnostic Errors/prevention & control; Female; Humans; Magnetic Resonance Imaging/methods; Mutation; Neoplasm Invasiveness; Neoplasm Staging; Ovary/diagnostic imaging; Ovary/metabolism; Ovary/surgery; Postoperative Complications/blood; Postoperative Complications/diagnosis; Postoperative Complications/psychology; Premenopause/physiology; Premenopause/psychology; Salpingo-oophorectomy/methods

Key words

aromatase inhibitor; bilateral oophorectomy; breast cancer; ovarian remnant syndrome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Cysts / Ovary / Postoperative Complications / Breast Neoplasms / Premenopause / Aromatase Inhibitors / Estradiol / Salpingo-oophorectomy Type of study: Diagnostic_studies Limits: Adult / Female / Humans Language: En Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google